Cipla Limited (NSE:CIPLA)
India · Delayed Price · Currency is INR 1,343.90
-12.50 (-0.92%)
At close: Feb 17, 2026
Cipla Market Cap
Cipla has a market cap or net worth of 1.09 trillion as of February 17, 2026. Its market cap has decreased by -5.38% in one year.
Market Cap
1.09T
Enterprise Value
985.29B
Revenue
279.67B
Ranking
n/a
PE Ratio
23.89
Stock Price
1,343.90
Market Cap Chart
Since May 30, 1996, Cipla's market cap has increased from 1.51B to 1.09T, an increase of 71,616.65%. That is a compound annual growth rate of 24.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 16, 2026 | 1.10T | -10.25% |
| Dec 31, 2025 | 1.22T | -1.14% |
| Dec 31, 2024 | 1.23T | 22.72% |
| Dec 29, 2023 | 1.01T | 15.87% |
| Dec 30, 2022 | 868.37B | 14.01% |
| Dec 31, 2021 | 761.69B | 15.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.08T |
| Divi's Laboratories | 1.63T |
| Zydus Lifesciences | 916.13B |
| Mankind Pharma | 860.00B |
| Aurobindo Pharma | 688.02B |
| Alkem Laboratories | 655.28B |
| Glenmark Pharmaceuticals | 573.01B |
| Laurus Labs | 546.58B |